Dr. Sulaiman Al Habib Medical Services Group Company (4013)

Basic

  • Market Cap

    SAR 98.7B

  • EV

    SAR 101.48B

  • Shares Out

    350M

  • Revenue

    SAR 9,275.62M

  • Employees

    —

Margins

  • Gross

    33.67%

  • EBITDA

    24.27%

  • Operating

    21.44%

  • Pre-Tax

    22.58%

  • Net

    21.16%

  • FCF

    0.64%

Returns (5Yr Avg)

  • ROA

    7.91%

  • ROE

    22.54%

  • ROCE

    15.52%

  • ROIC

    16.72%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    SAR 256

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    SAR 26.5

  • Earnings (Dil)

    SAR 5.61

  • FCF

    SAR 0.17

  • Book Value

    SAR 18.27

Growth (CAGR)

  • Rev 3Yr

    18.5%

  • Rev 5Yr

    12.14%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    24.87%

  • Dil EPS 5Yr

    20.18%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    18.9%

  • EBITDA Fwd 2Yr

    18.45%

  • EPS Fwd 2Yr

    17.23%

  • EPS LT Growth Est

    18.84%

Dividends

  • Yield

    —

  • Payout

    73.12%

  • DPS

    SAR 4.1

  • DPS Growth 3Yr

    39.82%

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    19.76%

Select a metric from the list below to chart it

Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM
Metric
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

4,587.6

5,016.3

5,861.6

7,250.5

8,310.7

9,275.6

Total Revenues % Chg.

-2.1%

9.3%

16.9%

23.7%

14.6%

15.6%

Cost of Goods Sold, Total

3,234.7

3,501.6

4,008.8

4,934.0

5,578.1

6,152.1

Gross Profit

1,352.9

1,514.7

1,852.8

2,316.4

2,732.7

3,123.5

Selling General & Admin Expenses, Total

551.4

647.0

737.9

850.3

1,032.2

1,134.5

Other Operating Expenses, Total

551.4

647.0

737.9

850.3

1,032.2

1,134.5

Operating Income

801.5

867.7

1,114.9

1,466.2

1,700.5

1,989.0

Interest Expense, Total

-19.3

-28.0

-48.5

-37.9

-49.4

-69.9

Interest And Investment Income

13.1

20.5

13.1

9.9

40.7

40.7

Net Interest Expenses

-6.2

-7.5

-35.4

-28.0

-8.6

-29.2

Income (Loss) On Equity Invest.

5.8

1.5

1.8

7.5

19.6

17.0

Other Non Operating Income (Expenses)

80.9

41.5

46.6

55.7

85.2

118.0

EBT, Excl. Unusual Items

882.0

903.3

1,127.8

1,501.3

1,796.7

2,094.9

Gain (Loss) On Sale Of Assets

-0.6

—

—

—

—

—

EBT, Incl. Unusual Items

881.4

903.3

1,127.8

1,501.3

1,796.7

2,094.9

Income Tax Expense

81.3

65.7

92.8

114.1

107.7

88.1

Earnings From Continuing Operations

800.1

837.6

1,035.0

1,387.3

1,688.9

2,006.8

Minority Interest

1.2

32.6

20.5

-10.7

-38.2

-44.3

Net Income

801.3

870.2

1,055.5

1,376.6

1,650.8

1,962.5

Net Income to Common Incl Extra Items

801.3

870.2

1,055.5

1,376.6

1,650.8

1,962.5

Net Income to Common Excl. Extra Items

801.3

870.2

1,055.5

1,376.6

1,650.8

1,962.5

Total Shares Outstanding

350.0

350.0

350.0

350.0

350.0

350.0

Weighted Avg. Shares Outstanding

350.0

350.0

350.0

350.0

350.0

350.0

Weighted Avg. Shares Outstanding Dil

350.0

350.0

350.0

350.0

350.0

350.0

EPS

2.3

2.5

3.0

3.9

4.7

5.6

EPS Diluted

2.3

2.5

3.0

3.9

4.7

5.6

EBITDA

1,001.7

1,073.8

1,378.1

1,728.3

1,960.3

2,251.5